Search Results
Jul 23, 2026, 02:00 ET Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System
EnduraTM Dry Tissue with Anti-Calcification TreatmentWire-Controlled Release MechanismSeadaptTM Self-Adaptive Anti-PVL SkirtV-Shaped Outflow DesignThree Radiopaque MarkersVenus-PowerX has already secured regulatory approvals in Argentina,
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 02:00 ET Venus Medtech gibt den Abschluss der Patientenrekrutierung für die entscheidende chinesische Studie zu Venus-PowerX bekannt - dem weltweit ersten vollständig reponierbaren, selbstexpandierenden TAVR-System mit Trockenventil
Dry-Gewebe mit Anti-KalzifizierungsbehandlungDrahtgesteuerter FreigabemechanismusSeadaptTM Selbstanpassender Anti-PVL-RandV-förmiges AuslassdesignDrei röntgendichte MarkerVenus-PowerX hat bereits behördliche Zulassungen in Argentinien,
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 02:00 ET A Venus Medtech anuncia a conclusão do recrutamento de pacientes para o estudo clínico pivotal na China do Venus-PowerX, o primeiro sistema TAVR com válvula seca autoexpansível totalmente recuperável do mundo
completaTecido Seco Venus EnduraTM com Tratamento AnticalcificanteMecanismo de liberação controlado por fioSaia anti-PVL auto-adaptativa SeadaptTMDesign de saída em forma de VTrês marcadores radiopacosA Venus-PowerX já obteve aprovações
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 02:00 ET Venus Medtech anuncia la finalización del reclutamiento de pacientes para el ensayo clínico de Venus-PowerX
Endura™ Dry Tissue con tratamiento anticalcificaciónMecanismo de liberación controlada por cableTejido Seadapt™ autoadaptable anti-PVLDiseño de salida en forma de VTres marcadores radiopacosVenus-PowerX ya ha obtenido las aprobaciones regulatorias en Argentina,
More news about: Venus Medtech (Hangzhou) Inc.
Jul 23, 2026, 02:00 ET Venus Medtech anuncia que ha finalizado el reclutamiento de pacientes en un ensayo clínico decisivo realizado en China para Venus-PowerX, el primer sistema TAVR del mundo con válvula seca autoexpandible y totalmente recuperable
anticalcificaciónMecanismo de liberación controlado por cableFaldón autoadaptativo SeadaptTM contra fugas paravalvulares (anti-PVL)Diseño de salida en forma de VTres marcadores radiopacosVenus-PowerX ya ha obtenido las autorizaciones reglamentarias
More news about: Venus Medtech (Hangzhou) Inc.
May 26, 2026, 09:27 ET Venus Medtech veranstaltet ersten globalen Partnergipfel in Paris
Risiko einer Obstruktion des linksventrikulären Ausflusstrakts (LVOT) verringern soll, sowie ein adaptiver Dichtungsmechanismus, der paravalvuläre Lecks (PVL) minimieren soll. Der Präsentation zufolge wird davon ausgegangen, dass die derzeit verfügbaren Gerätegrößen für etwa 85 % der Zielpatientenpopulation
More news about: Venus Medtech
May 26, 2026, 03:00 ET Venus Medtech Hosts Inaugural Global Partner Summit in Paris
intended to reduce left ventricular outflow tract (LVOT) obstruction risk, and an adaptive sealing mechanism designed to minimize paravalvular leak (PVL). According to the presentation, current device sizing is expected to address approximately 85% of the target patient population.The session also
More news about: Venus Medtech
Apr 08, 2026, 14:19 ET MiRus Begins Patient Enrollment in the STAR Randomized Trial of the Siegel™ Transcatheter Aortic Valve
Cardiovascular Surgery and the Marcus Valve Center, Piedmont Heart Institute. "An 8 French system with such precise placement, low gradients, and no PVL is a combination I never expected in THV. A THV without nickel is also much needed. The STAR trial is the most exciting trial in the management of aortic
More news about: MiRus
Oct 29, 2025, 21:00 ET Jenscare released its multi-product portfolio's, including LuX-Valve Plus TRINITY study, JensClip and Ken-Valve, remarkable clinical outcomes at TCT 2025 in the U.S.
integrated clamping and radial force anchoring mechanism which can provide reliable anchoring force. It has a leak-proof ring which is expected to minimize PVL post-implantation. It provides large size options which enables wide applicability on large aortic valve anatomies. The deflectable delivery system allows
More news about: Jenscare Scientific Co., Ltd.
Sep 12, 2025, 11:27 ET Pure Vita Labs Launches Can-Whey: Canada's First 100% Canadian-Made Whey Protein Powder, Celebrating National Pride with Vanilla and Chocolate Milkshake Flavors
www.can-whey.ca. About Pure Vita Labs (PVL)PVL is a Canadian, family-owned sports nutrition company dedicated to integrity and excellence. For over 29 years, PVL has formulated and manufactured high-quality, 100% natural supplements in-house, delivering
More news about: Pure Vita Labs